Abstract:Object: To construct,express,purify anti-VEGF antibody Fab fragment in E. coli,and to assay its activity. Through controlling the fermentation conditions,Fab fragment can be achieved actively and largely by secreting to the periplasmic space or extracellular medium. Methods: The co-expression plasmid pET30a-LC-HC which has the OmpA signal peptide,SD sequence and the T7 promoter before Fd chain and L chain was successfully constructed. Then the plasmid was transformed into Escherichia coil BL21( DE3). The inducing condition including medium,temperature and IPTG concentration was also optimized. Results: The best shaking fermentation condition on Escherichia coil periplasmic secretory expression: in 1L XY1 medium that including 1.5% Tryptone,1% Yeast Extract,0. 5% Glucose,0. 15% NaCl,0. 1% NH4 Cl,0. 08% MgCl2~ 6H2 O,the strains were cultured with 10% inoculum at 37℃,and then added 0. 1mM IPTG until the late logarithmic growth phase( OD600 was about 2) to induced overnight( about 16h) at 16 ℃. Except periplasmic expression,there is also a considerable part of Fab that secrete into the medium. Fab fragment which secrected into the periplasm was extracted by breaking periplasm of bacteria. At the same time,the culture medium were concentrated with the hollow fiber column,and further purified Fab by ProteinG affinity chromatography. At last,we got the purified Fab antibody fragments with more than 90% purity by SDS-PAGE analysis. The protein concentration is measured with Brandford detection method. The amount of purified Fab from periplasm and medium is up to 0. 4mg /L. Taking the VEGF165 as the binding antigen,the half-maximal effective concentration( EC50) of the purified Fab is30 ng /ml being analyzed indirectly by ELISA,which show a high antigen-binding activity. Then 3. 7L fermentor with 2L volume of XY1 culture mediun is used to do small pilot scale fermentation. The final cell yield is 30 g /L in the 3. 7L fermenter with 2L culture medium,and the concentration of Fab antibody purified by affinity column is1. 94 mg /L. Conclusion: Fab fragment can be successful and high-efficiently secrected into the periplasmic space and extracellular medium through constructing the co-expression vector and optimizing the fermentation condition,and has highly activity against VEGF. It provides research basis for large-scale preparation of Fab antibody fragment.

Improvement of Soluble Expression of Anti-VEGF Fab Fragments in E.coli

The Secretory Expression of an Anti-VEGF Antibody Fab Fragment in E.coli

Constitutive expression of Vitreoscilla haemoglobin in Sphingomonas elodea to improve gellan gum production

A General Platform for Efficient Extracellular Expression and Purification of Fab from Escherichia Coli.

High-Level Soluble Expression of Higf-1 Fusion Protein in Recombinant Escherichia Coli

A Phoa-Stii Based Method For Efficient Extracellular Secretion And Purification Of Fab From Escherichia Coli

Improving Expression of scFv Fragments by Co-expression of Periplasmic Chaperones

Co-expression of chaperones for improvement of soluble expression and purification of an anti-HER2 scFv in Escherichia coli

Development of a protein-solubilizing expression method based on the synergistic action of intein ΔI-CM and the solubility enhancer elastin-like polypeptide

Functional expression of Bacillus subtilis xylanase A in an Escherichia coli derived cell-free protein synthesis system and subsequent expression improvement via DNA gel technique

Recent advancements in soluble expression of recombinant antibody fragments in microbial host systems

Effect of Molecular Chaperone on the Soluble Expression of Recombinant Fab Fragment in E. coli

Engineering Production of Functional Scfv Antibody in E. Coli by Co-Expressing the Molecule Chaperone Skp

Highly Expressed Soluble Recombinant Anti-GFP VHHs in Escherichia coli via Optimized Signal Peptides, Strains, and Inducers

Efficient Molecular Biological Manipulations with Improved Strategies Based on Novel Escherichia Coli Vectors.

Strategies and Applications of Antigen-Binding Fragment (Fab) Production in Escherichia coli

High-yield expression of human vascular endothelial growth factor VEGF(165) in Escherichia coli and purification for therapeutic applications

Production of Soluble and Functional Engineered Antibodies in Escherichia Coli Improved by Fkpa

Development of a high yielding E. coli periplasmic expression system for the production of humanized Fab' fragments

Environmental Stimuli on the Soluble Expression of Anti-Human Ovarian Carcinoma × Anti-Human CD3 Single-Chain Bispecific Antibody in Recombinant Escherichia Coli

Soluble Expression and Purification of the Catalytic Domain of Human Vascular Endothelial Growth Factor Receptor 2 in Escherichia Coli